About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Orbital Cysticercosis Presenting as Swelling in the Medial Canthus

rigevidon pris

rigevidon rigevidogenerati.website rigevidon pris
Kaleem Ahmad, Sajid Ansari, Mukesh Kumar Gupta, Kanchan Dhungel, Mohammad Azfar Siddiqui1, Raj Kumar Rauniyar
From the Department of Radiodiagnosis & Imaging, B. P. Koirala Institute of Health Sciences, Dharan, Nepal; Department of Radiodiagnosis, Jawaharlal Nehru Medical College1, A.M.U., Aligarh, Uttar Pradesh, India.
Corresponding Author:
Dr. Kaleem Ahmad
Email: drkalim17@yahoo.co.in
Received: 15 JUNE 2013 Accepted: 24 JUNE 2013 Published Online: 05-SEP-2013
DOI: http://dx.doi.org/10.17659/01.2013.0071
Abstract
The orbital involvement of the cysticercosis is a rare manifestation involving eyelids, extraocular muscles, orbit, conjunctiva, anterior chamber, uvea, retina, vitreous and optic nerve. All the extraocular muscles are involved in myocysticercosis. Ultrasonography and Computed tomography are the imaging modalities for evaluation of orbital cysticercosis. The patients can be treated with systemic steroids and albendazole; however surgical excision is the treatment of choice. Hereby, we report an unusual case of orbital myocysticercosis with involvement of medial rectus muscle and swelling in the region of left medial canthus. 
Keywords : Cysticercosis, Tomography, Conjunctiva, Anterior Chamber, Albendazole, Retina.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025